XML 78 R63.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation - Additional Information (Details)
12 Months Ended
Dec. 30, 2022
shares
Dec. 31, 2024
USD ($)
purchase_period
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Jun. 30, 2024
shares
Equity Incentive Plan          
Term of stock options   10 years      
Stock-based compensation expense | $   $ 21,032,000 $ 27,480,000 $ 42,531,000  
Granted   0 0    
Tax benefits of the stock-based compensation expense | $   $ 0      
Tax benefits from the exercise of stock options | $   0      
Capitalized stock-based compensation expense | $   400,000 $ 700,000 $ 1,000,000.0  
Stock-based compensation expense | $   $ 21,100,000      
Remaining weighted average vesting period   1 year 10 months 24 days      
Class A Common Stock | Common Stock          
Equity Incentive Plan          
Common stock issued for employee stock purchase plan (in shares)   671,435      
Nonemployee          
Equity Incentive Plan          
Granted   0 0 0  
Service Based Stock Options          
Equity Incentive Plan          
Number of accelerated shares (in shares) 1,700,000        
Expense related to acceleration | $     $ 7,800,000    
Service Based Stock Options | Maximum          
Equity Incentive Plan          
Term of stock options   10 years      
Service Based Restricted Stock Options          
Equity Incentive Plan          
Number of accelerated shares (in shares) 300,000        
Performance Based Restricted Stock Units          
Equity Incentive Plan          
Number of accelerated shares (in shares) 100,000        
Performance Based Restricted Stock Units | Employee          
Equity Incentive Plan          
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)       200,000  
Outstanding restricted stock units          
Equity Incentive Plan          
Total fair value | $   $ 10,400,000 $ 7,300,000 $ 10,700,000  
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)   15,838,283 16,082,613    
Market-based restricted stock | Employee          
Equity Incentive Plan          
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period (in shares)   1,000,000.0 1,800,000    
Stock-based compensation expense | $   $ 2,000,000.0 $ 2,500,000    
2012 Plan          
Equity Incentive Plan          
Common Stock reserved for issuance (in shares)   4,800,000      
2020 Plan          
Equity Incentive Plan          
Common Stock reserved for issuance (in shares)   53,500,000      
Common shares remain available for issuance (in shares)   17,200,000      
ESPP 2024          
Equity Incentive Plan          
Common stock reserved and available for issuance (in shares)         4,200,000
Length of total offering period   24 months      
Number of offering periods | purchase_period   4      
Length of individual offering periods   6 months      
Purchase price percentage of closing market price on the first day of the offering period   85.00%      
Purchase price percentage of closing market price on the day of purchase   85.00%